Larvol Delta - Targeting-BRD4-and-PI3K-signaling-pathways-for-the-treatment-of-medulloblastoma

SF2523 - SignalRx, ADYA Consulting

http://www.ncbi.nlm.nih.gov/pubmed/36599397

Jan 5, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next